Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

Taro PharmaceuticalsTaro Pharmaceuticals
VS
UCBUCB
Taro Pharmaceuticals

Taro Pharmaceuticals

undefined, undefined, undefined, undefined, US

Last Update: 02/04/2026

View Profile
Between 700 and 749
http://www.taro.com
724/1000Moderate

Established in 1950, Taro Pharmaceutical Industries Ltd. is a research-based, international, specialty pharmaceutical company that develops, manufactures and markets prescription and over-the-counter pharmaceutical products. Taro’s research programs and niche strategy h...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:1,518
Subsidiaries:3
12-month incidents
0
Known data breaches
1
Attack type number
1
UCB

UCB

Allée de la Recherche, 60, Brussels, BE

Last Update: 14/06/2026

View Profile
Between 800 and 849
http://www.ucb.com
815/1000Good

At UCB, we believe everyone deserves to live the best life they can - as free as possible from the challenges and uncertainty of disease. Our purpose is to support people living with severe central nervous system and immunological conditions by delivering meaningful sol...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:14,451
Subsidiaries:0
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Ranges Comparison

Based On Specific Ai Models Category
Taro Pharmaceuticals

Taro Pharmaceuticals

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
UCB

UCB

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Taro Pharmaceuticals in 2026.

Incidents

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for UCB in 2026.

Incidents

Incident History - Taro Pharmaceuticals (X = Date, Y = Severity)

Taro Pharmaceuticals cyber incidents detection timeline including parent company and subsidiaries.

R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - UCB (X = Date, Y = Severity)

UCB cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
Taro Pharmaceuticals

Taro Pharmaceuticals

Incidents
🔒 Incident : Breach
TAR937072825
UCB

UCB

Incidents
No explicit notable incidents reported.

FAQ

Between Taro Pharmaceuticals company and UCB company, which one has the best AI Cybersecurity Score ?
Between Taro Pharmaceuticals company and UCB company, which one has experienced more cyber incidents in the past ?
Between Taro Pharmaceuticals company and UCB company, which one has experienced more cyber incidents this year ?
Between Taro Pharmaceuticals company and UCB company, which one has experienced at least one ransomware attack ?
Between Taro Pharmaceuticals company and UCB company, which one has experienced at least one data breach ?
Between Taro Pharmaceuticals company and UCB company, which one has experienced at least one targeted cyberattack ?
Between Taro Pharmaceuticals company and UCB company, which one has experienced at least one vulnerability ?
Between Taro Pharmaceuticals company and UCB company, which one holds the most compliance certifications ?
Between Taro Pharmaceuticals company and UCB company, which one holds the fewest compliance certifications ?
Between Taro Pharmaceuticals company and UCB company, which one has the most subsidiaries ?
Between Taro Pharmaceuticals company and UCB company, which one has the largest number of employees ?
Between Taro Pharmaceuticals and UCB, which company holds both SOC 2 Type 1 certifications ?
Between Taro Pharmaceuticals and UCB, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - Taro Pharmaceuticals or UCB ?
Which company is PCI DSS compliant - Taro Pharmaceuticals or UCB ?
Between Taro Pharmaceuticals and UCB, which company complies with HIPAA regulations for healthcare data ?
Between Taro Pharmaceuticals and UCB, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-74250
SUMMARY

In OpenStack Ironic before 38.0.1, the autodetect deploy interface may fail to run cleaning immediately after enrollment with, or changing to, the autodetect deploy interface.

PUBLISHED
Date2026-08-14
UPDATED
Date2026-08-14
RISK INFORMATION (Score: 6.3)
CVSS3
Base Score: 6.3
Complexity: HIGH
CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:C/C:H/I:N/A:N
IMPACT SCORE
4
EXPLOITABILITY
1.8
CVE-2026-74247
SUMMARY

A flaw was found in Red Hat Quay. A user with FEATURE_BUILD_SUPPORT enabled and repository write access can exploit a Server-Side Request Forgery (SSRF) vulnerability within the build API. This allows the user to provide a malicious URL, causing the Quay builder to make requests to internal network addresses. Such an action could lead to the disclosure of sensitive internal information.

PUBLISHED
Date2026-08-14
UPDATED
Date2026-08-14
RISK INFORMATION (Score: 4.2)
CVSS3
Base Score: 4.2
Complexity: HIGH
CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:U/C:L/I:L/A:N
IMPACT SCORE
2.5
EXPLOITABILITY
1.6
CVE-2026-74245
SUMMARY

A flaw was found in Red Hat Quay's exported logs feature. An unauthenticated attacker with a valid file ID could download exported action logs without proper authorization. While file IDs are complex, they can be intercepted from plaintext email or webhook callbacks. This vulnerability leads to information disclosure, potentially exposing sensitive data such as usernames, email addresses, IP addresses, and action-specific metadata.

PUBLISHED
Date2026-08-14
UPDATED
Date2026-08-14
RISK INFORMATION (Score: 5.9)
CVSS3
Base Score: 5.9
Complexity: HIGH
CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:H/I:N/A:N
IMPACT SCORE
3.6
EXPLOITABILITY
2.2
CVE-2026-74244
SUMMARY

A flaw was found in Red Hat Quay's Stripe billing webhook handler. This vulnerability allows an unauthenticated attacker to forge billing events by sending crafted JSON requests to the `/webhooks/stripe` endpoint without validating the Stripe-Signature header. Successful exploitation can lead to the unauthorized resetting of a namespace's build quota to its maximum and trigger unsolicited billing emails to namespace administrators.

PUBLISHED
Date2026-08-14
UPDATED
Date2026-08-14
RISK INFORMATION (Score: 5.9)
CVSS3
Base Score: 5.9
Complexity: HIGH
CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:N/I:H/A:N
IMPACT SCORE
3.6
EXPLOITABILITY
2.2
CVE-2026-74243
SUMMARY

A flaw was found in Red Hat Quay. When the SECURITY_SCANNER_V4_PSK (pre-shared key) is not set, a remote unauthenticated attacker can send POST requests to the security scanner notification endpoint. This allows the attacker to flood the notification queue and inject path traversal characters into Clair API URL paths. The primary consequence is worker resource exhaustion and blind path manipulation on the configured Clair host, potentially leading to a denial of service.

PUBLISHED
Date2026-08-14
UPDATED
Date2026-08-14
RISK INFORMATION (Score: 6.5)
CVSS3
Base Score: 6.5
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:L/A:L
IMPACT SCORE
2.5
EXPLOITABILITY
3.9